U.S. pharma big copyright scrapped two experimental weight loss capsules last 12 months—a at the time-day by day pill, lotiglipron, on account of elevated liver enzymes in addition to a twice-each day capsule, danuglipron, on account of sturdy Negative effects—but CEO Albert Bourla h